Live feed
Filing
SC 13G
SC 13G0000921895-15-002191·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
CTI BIOPHARMA CORP
Security class unavailable · CUSIP: 12648L106
Event date: 2015-09-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-15-002191
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Oct 02, 2015
- Reporting period
- Sep 24, 2015
- Description
- Schedule 13G beneficial ownership